ATE401094T1 - Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist - Google Patents

Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist

Info

Publication number
ATE401094T1
ATE401094T1 AT00955489T AT00955489T ATE401094T1 AT E401094 T1 ATE401094 T1 AT E401094T1 AT 00955489 T AT00955489 T AT 00955489T AT 00955489 T AT00955489 T AT 00955489T AT E401094 T1 ATE401094 T1 AT E401094T1
Authority
AT
Austria
Prior art keywords
cancer cell
extract
ginkgo biloba
gkb
patient
Prior art date
Application number
AT00955489T
Other languages
English (en)
Inventor
Katy Drieu
Vassilios Papadopoulos
Original Assignee
Sod Conseils Rech Applic
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Univ Georgetown filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE401094T1 publication Critical patent/ATE401094T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00955489T 1999-08-12 2000-08-11 Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist ATE401094T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14860499P 1999-08-12 1999-08-12

Publications (1)

Publication Number Publication Date
ATE401094T1 true ATE401094T1 (de) 2008-08-15

Family

ID=22526515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00955489T ATE401094T1 (de) 1999-08-12 2000-08-11 Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist

Country Status (11)

Country Link
EP (1) EP1200108B1 (de)
JP (2) JP2003507336A (de)
KR (1) KR20020060154A (de)
CN (1) CN1361697A (de)
AT (1) ATE401094T1 (de)
AU (1) AU6768900A (de)
CA (1) CA2378052C (de)
DE (1) DE60039517D1 (de)
ES (1) ES2307529T3 (de)
NO (1) NO20020666D0 (de)
WO (1) WO2001012208A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001277786A1 (en) * 2000-08-04 2002-02-18 Angiolab, Inc. Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase
WO2004019900A1 (en) * 2002-08-27 2004-03-11 Societe Des Produits Nestle Preventing or treating epithelial tissue damage or hair loss
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
CN101027069A (zh) * 2003-11-28 2007-08-29 宝生物工程株式会社 神经酰胺酶抑制剂
KR20050081597A (ko) * 2004-02-16 2005-08-19 한국 메디텍 제약 주식회사 은행잎추출물을 유효성분으로 함유하는 발암억제효과를갖는 골다공증 치료제
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
CN105833016A (zh) * 2016-05-26 2016-08-10 宋羽 一种治疗卵巢癌的中药组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
DE4105570A1 (de) * 1991-02-22 1992-08-27 Helmut Dr Med Scholle Verwendung eines bakterien- und eiweissfreien filtrats
DE4208868A1 (de) * 1992-03-04 1993-09-09 Michaelis Peter Dr Med Verwendung eines arzneimittels zur behandlung von metastatischen krebserkrankungen
JPH07126180A (ja) * 1993-11-01 1995-05-16 Daicel Chem Ind Ltd 発癌抑制剤
JPH0977674A (ja) * 1995-07-07 1997-03-25 Kawashima Takaaki 薬用乾燥酵母含有機能性組成物
JPH09110713A (ja) * 1995-10-13 1997-04-28 Nippon Green Ueebu Kk グルタチオン−ｓ−トランスフェラーゼ活性化剤並びにそれを含む医薬品及び飲食物
CZ140598A3 (cs) * 1995-11-09 1998-10-14 Societe De Conseils De Recherches Et D'applications Scientifiques S. A. (S. C. R. A. S.) Ginkgolidy pro inhibici membránové exprese
JPH11209274A (ja) * 1998-01-22 1999-08-03 Bae O-Sung 疾病治療用喫煙物
US7267977B2 (en) * 1998-03-25 2007-09-11 Georgetown University Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer

Also Published As

Publication number Publication date
CN1361697A (zh) 2002-07-31
NO20020666L (no) 2002-02-11
JP2003507336A (ja) 2003-02-25
EP1200108B1 (de) 2008-07-16
AU6768900A (en) 2001-03-13
DE60039517D1 (de) 2008-08-28
EP1200108A1 (de) 2002-05-02
CA2378052A1 (en) 2001-02-22
KR20020060154A (ko) 2002-07-16
ES2307529T3 (es) 2008-12-01
JP2007126472A (ja) 2007-05-24
WO2001012208A1 (en) 2001-02-22
CA2378052C (en) 2010-03-23
NO20020666D0 (no) 2002-02-11

Similar Documents

Publication Publication Date Title
ATE286053T1 (de) Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2003089457A3 (en) Peptide inhibitors of protein kinase c ϝ for pain management
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
WO2003087831A3 (en) Proteins involved in breast cancer
WO2007030680A3 (en) Triazole derivatives useful as axl inhibitors
WO2004043374A3 (en) Methods and compositions for treating cancer using proteasome inhibitors
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
AU2003253877A1 (en) Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs
WO2004048938A3 (en) Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
DE50010833D1 (de) Pharmazeutisches präparat enthaltend diamorphin und vitamin e seine verwendung zur behandlung der opiatsucht
ATE334985T1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE326239T1 (de) Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
WO2003070283A3 (en) Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
AU3208200A (en) A novel method for designing protein kinase inhibitors
ATE249220T1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
DE502007005843D1 (de) Verwendung von glycyrrhetinsäure und/oder glycyrrhizin zur herstellung von zubereitungen zur bräunung der haut
ATE401094T1 (de) Verwendung eines ginkgo extraktes zur behandlung von krebs welcher durch überexpression von peripherem benzodiazepin rezeptor protein gekennzeichnet ist
UA84954C2 (ru) Конденсированные пиримидоны, пригодные для лечения и профилактики злокачественного новообразования
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
ATE173620T1 (de) Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs
IL149416A0 (en) Human enzymes of the metalloprotease family
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties